جست‌وجوی استاد و پژوهشگر

Camila Aquinoمشاهده پروفایل

استادیار

• Movement Disorders
• Parkinson's Disease
• Deep Brain Stimulation
• +۵ مورد دیگر

Dr. Camila Aquino serves as Assistant Professor in both the Department of Clinical Neurosciences and Department of Community Health Sciences at the University of Calgary's Cumming School of Medicine, and is a Full Member of the Hotchkiss Brain Institute. As Medical Director of the Deep Brain Stimulation Program, she specializes in Parkinson's disease, essential tremor, dystonia, and chorea management, including EMG-guided botulinum toxin injections. Her educational background includes: M.D. in Medicine from Escola Superior de Ciencias da Santa Casa (2005) M.S. in Neurosciences from Federal University of Sao Paulo (2012) Ph.D. in Neurosciences from Federal University of Sao Paulo (2019) M.S. in Health Research Methods, Clinical Epidemiology from McMaster University (2020) Dr. Aquino's research addresses unmet needs in movement disorders through innovative clinical trial designs for Parkinson's disease, focusing on precision-medicine approaches, early intervention, and outcome optimization. She actively evaluates neuromodulation therapies including Deep Brain Stimulation, Spinal Cord Stimulation, and MRgFUS, with emphasis on expanding indications and improving patient outcomes. As an International Parkinson and Movement Disorder Society member, she chairs the web-based learning committee and serves on evidence-based medicine and outcome measure committees. Analysis of her 15 most recent publications (2021-2025) reveals a cohesive research trajectory centered on Parkinson's disease management, with dominant themes in motor fluctuation treatments, deep brain stimulation methodology, and clinical trial innovation. Her work bridges fundamental clinical practice guidelines with advanced neuromodulation technologies, demonstrating consistent commitment to evidence-based solutions for movement disorders. Her scientific recognition includes: Parkinson Canada research grant Mohammed Al Zaibak Foundation scholarship CAPES scholarship from Brazilian Ministry of Education Dr. Aquino has secured significant research funding supporting clinical trials in Parkinson's disease neuroprotection and neuromodulation therapies. While specific student advisees aren't listed, her leadership of the DBS Program and active clinical trial portfolio indicate substantial mentorship responsibilities. Her grant portfolio emphasizes translational research with direct clinical impact. She directs the University of Calgary's Deep Brain Stimulation Program and contributes to the MRI-guided focused ultrasound initiative. Through her International Parkinson and Movement Disorder Society committee roles, she shapes global educational standards and evidence-based practices in movement disorders.

Joshua J. Solanoمشاهده پروفایل

دانشیار

• Emergency Medicine
• Geriatric Emergency Care
• Medical Education
• +۴ مورد دیگر

Joshua J. Solano, M.D., FAAEM is an Associate Professor of Emergency Medicine and Clerkship Director for the Emergency Medicine Residency program at the Florida Atlantic University Charles E. Schmidt College of Medicine. As Clerkship Director, he works alongside residents to promote best practices for emergency department patient care. Dr. Solano is board certified in emergency medicine and maintains active membership in the American College of Emergency Physicians and the American Academy of Emergency Medicine. Dr. Solano's educational background includes a BS in Biology and BA in History from Duke University, followed by his MD from the University of Florida. He completed his emergency medicine residency at Beth Israel Deaconess Medical Center in Boston and served on faculty at Harvard Medical School as an instructor and assistant program director before joining FAU. In his final year in Boston, he completed the Rabkin Medical Education Fellowship. Dr. Solano's research focuses on geriatric emergency medicine, particularly head trauma management in elderly patients, anticoagulation risks, and emergency department quality assurance. His recent publications demonstrate a strong emphasis on developing clinical decision rules for geriatric head trauma and understanding medication interactions in older emergency patients. He has also contributed significantly to medical education literature, developing innovative residency training curricula. His scholarly work shows a clear progression toward establishing evidence-based guidelines for geriatric emergency care, with numerous publications on intracranial hemorrhage risk assessment, anticoagulation management, and fall prevention strategies. Dr. Solano's research bridges clinical practice with educational innovation, making significant contributions to both patient care protocols and emergency medicine training. 2017: Attending Role Model Award, Beth Israel Deaconess Medical Center 2016-2017: Rabkin Medical Education Fellowship 2011: Alpha Omega Alpha Medical Honor Society 2011: Chapman Humanism Society 2010: Equal Access Clinic Service Award 2010: Lawrence M. Goodman Award for Medical Student Research 2010: Community Service Award As Clerkship Director, Dr. Solano oversees medical student education in emergency medicine and has implemented electronic evaluation systems that have increased the quality and quantity of student assessments. His clinical work includes staff positions at Bethesda East Hospital and Delray Medical Center. Dr. Solano's research program demonstrates strong institutional support through multiple publications and ongoing investigations into geriatric emergency care protocols.

Angelina Wangمشاهده پروفایل

استادیار

• Machine Learning Fairness
• Algorithmic Bias
• Responsible AI
• +۳ مورد دیگر

Angelina Wang is an incoming Assistant Professor at Cornell Tech and the Department of Information Science at Cornell University, starting Fall 2025. Her research focuses on responsible AI, particularly machine learning fairness and algorithmic bias. She holds a Ph.D. in Computer Science from Princeton University and a B.S. in Electrical Engineering and Computer Science from UC Berkeley. Current postdoctoral work at Stanford’s HAI and RegLab explores sociotechnical challenges in AI deployment. Her research addresses fairness evaluation in generative AI, societal impacts of AI systems, and ethical trade-offs in algorithm design. Notable awards include the NSF GRFP, Siebel Scholarship, and Microsoft AI & Society Fellowship. Her work bridges technical and social dimensions of AI, emphasizing human-centered evaluation and interdisciplinary collaboration. Recent publications span medical AI applications (e.g., Alzheimer’s subphenotypes, corticosteroid treatment efficacy) and foundational fairness research. She advocates for proactive ethical considerations in technical work, citing examples like surveillance risks in facial recognition and dataset biases in computer vision. Angelina advises prospective PhD students in Cornell’s Information Science program and collaborates on projects like SciDaSynth for scientific knowledge synthesis. Her advocacy includes challenging fairness impossibility theorems and promoting algorithmic pluralism in auditing practices.

Jenni Ilomakiمشاهده پروفایل

دانشیار

• Clinical Pharmacy
• Pharmacoepidemiology
• Public Health
• +۳ مورد دیگر

Associate Professor Jenni Ilomaki holds a position at Monash University's Centre for Medicine Use and Safety. With expertise in clinical pharmacy, epidemiology, and public health, she leads a research group analyzing administrative claims data. Her work spans collaborations with governmental and non-governmental organizations globally, yielding over 150 peer-reviewed publications and $4 million in grants. She previously served as Chair of ASCEPT's Pharmacoepidemiology Special Interest Group and currently serves as Science Lead for the Monash Addiction Research Centre and Executive Editor of the British Journal of Clinical Pharmacology. Education includes a Bachelor of Science (Pharmacy) from the University of Kuopio (1999) and Master of Science (Pharmacy) from the University of Kuopio (2004). She completed a PhD in alcohol epidemiology at the University of Eastern Finland (2011) and a postdoc at the University of South Australia (2011-2014). Notable recognitions include Young Epidemiologist of the Year (2011) and the Ronald D. Mann Best Paper Award (2021). Key research focuses on quality use of medicines, medicine safety, large population studies, and innovative epidemiological methods. Major projects include developing clinical decision support tools for cardiovascular prevention, analyzing preventable hospitalizations in aged care, and investigating psychotropic medication trends in youth. Her work contributes to UN Sustainable Development Goals related to health equity and non-communicable disease reduction. Recent publications emphasize drug repurposing (e.g., SGLT2 inhibitors), opioid prescribing patterns, hip fracture outcomes, and dementia detection algorithms. She chairs multinational studies on stroke and myocardial infarction cost burdens, demonstrating interdisciplinary impact across pharmacology, epidemiology, and health economics.

Amanda Watsonمشاهده پروفایل

استادیار

• Wearable Technology
• Biomedical Engineering
• Cyber-Physical Systems
• +۲ مورد دیگر

Amanda Watson is an Assistant Professor in Electrical and Computer Engineering at the University of Virginia, with joint appointments in Computer Science. She leads the Watson Research Lab within the UVA Link Lab, a multidisciplinary center for Cyber-Physical Systems (CPS) and Internet of Medical Things (IoMT) research. Her work bridges wearable technology with healthcare and athletic performance applications, focusing on noninvasive monitoring, physiological signal analysis, and safety-critical medical devices. She is also the cofounder and CEO of Luminosity Wearables, commercializing a noninvasive continuous glucose monitor. Education: PhD in Computer Science (2020) - College of William & Mary MSc in Computer Science (2016) - College of William & Mary Bachelors in Computer Science and Mathematics (2014) - Drury University Her research spans multiple domains including: Wearable spectroscopy for nutrition and skin health Machine learning for drug overdose and fall risk detection Biomechanical monitoring in sports medicine Wearable support for visual and neurological impairments IoMT device integration and analytics Recent publications (2024-2025) show strong emphasis on calibration-free physiological monitoring systems, with technical contributions in spectral analysis , multi-wavelength sensing , and rapid prototyping for healthcare wearables. Applications range from maternal health to gerontological social isolation detection. Lab and Team: The Watson Research Lab at UVA develops wearable solutions for clinical and athletic contexts, with ongoing collaborations in the PRECISE Center at University of Pennsylvania and LENS lab at William & Mary alumni network. She works with multidisciplinary teams including engineers, clinicians, and data scientists.

Richard Boyceمشاهده پروفایل

دانشیار

• Clinical Decision Support Systems
• Pharmacovigilance
• Drug Interaction Analysis
• +۳ مورد دیگر

Richard Boyce is an Associate Professor in the Department of Biomedical Informatics at the University of Pittsburgh's School of Computing and Information. His work focuses on clinical decision support systems (CDSS), pharmacovigilance, and distributed knowledge bases. He leads research in drug interaction analysis, particularly involving natural products like cannabis, and develops machine learning tools for healthcare applications. His address is 530 DBMI Building, Pittsburgh, PA 15260, with contact email rdb20@pitt.edu. Boyce’s research integrates clinical and pharmacological data to improve patient safety through advanced analytics. Recent projects include predicting Alzheimer’s disease using EHR data, falls prediction in nursing homes, and optimizing CDSS modules for resource-limited settings. His team also develops open-source knowledge graphs for life sciences, enhancing data interoperability. Education: Details not explicitly listed in the provided text. Labs/Teams: Affiliated with the Department of Biomedical Informatics and School of Computing and Information at Pitt. Publications highlight his contributions to pharmacovigilance signal detection, machine learning in healthcare, and ontology engineering. Notable works include studies on cannabis-drug interactions and CDSS design for clinical practice.

• Data Analytics
• Healthcare Systems
• Predictive Modeling
• +۳ مورد دیگر

Dr. Nasibeh Azadeh-Fard is an Assistant Professor in the Department of Industrial and Systems Engineering at Rochester Institute of Technology (RIT), part of the Kate Gleason College of Engineering. She directs the Healthcare Analytics Lab, focusing on applying advanced analytics to healthcare data for decision-making. Her expertise includes data analytics, healthcare systems engineering, and risk analysis. Dr. Fard holds a B.S. in Information Technology Engineering from Iran University of Science and Technology, and M.S. and Ph.D. in Industrial and Systems Engineering from Virginia Tech. She has served as a visiting professor at RIT and a postdoctoral fellow at Clemson University’s Risk Engineering and System Analytics Center, collaborating with AIG on risk mitigation. Her research emphasizes predictive modeling, hospital readmission prediction, and machine learning applications in healthcare. Notable projects include analyzing sepsis risk, COPD patient readmissions, and stroke rehabilitation using wearable sensors. She has secured a $21,000 FEAD grant for AI-driven readmission prediction. Dr. Fard advises several PhD students, including Behrad Barghi, Chiara Duenas, and Marzieh Amiri-Shahbazi, who have contributed to peer-reviewed publications and academic milestones. The Healthcare Analytics Lab collaborates with institutions like Rochester Regional Health and UR Medicine to translate research into practical solutions. Dr. Fard teaches courses on data analytics, predictive modeling, decision analysis, and forecasting methods, emphasizing real-world engineering applications. Her work bridges academia and healthcare practice, aiming to enhance patient outcomes through data-driven strategies.

• Medical Biochemistry
• Clinical Biochemistry
• Oxidative Stress
• +۵ مورد دیگر

Prof. Dr. Aynur KIRBAŞ is a distinguished Professor of Medical Biochemistry at Ahi Evran University, Faculty of Medicine, where she has served since 2023. Previously, she was an Associate Professor at Kırşehir Ahi Evran University (2022-2023) and Recep Tayyip Erdoğan University (2013-2022), and an Assistant Professor at Recep Tayyip Erdoğan University (2009-2013). She currently serves as both Professor and Head of Department at Ahi Evran University, and as Education Coordinator since 2025. Dr. KIRBAŞ earned her Bachelor's Degree from Atatürk University, Faculty of Medicine (1994-2000) and completed her PhD/Medical Specialization at Süleyman Demirel University, Faculty of Medicine Hospital Application and Research Center (2002-2007). She has obtained proficiency in English with a score of 77 on the ÜDS exam in Fall 2010. Her research focuses on medical biochemistry, particularly oxidative stress, inflammation markers, and biomarker research in various clinical conditions. With 102 publications to her name including 84 articles, she has made significant contributions to understanding biochemical markers in neurological disorders, cardiovascular disease, metabolic conditions, and inflammatory processes. Her work frequently examines YKL-40, copeptin, and other novel biomarkers across diverse clinical settings from stroke to rheumatological conditions. Dr. KIRBAŞ has led or participated in 17 research projects, primarily funded by higher education institutions, investigating topics ranging from hirudotherapy effects to novel inflammatory markers in pleural effusion. Her most recent projects examine the effects of hirudotherapy on exercise-induced fatigue and the relationship between serum BDNF and NGF levels in restless leg syndrome. She has received recognition for her work, including an award in 2006 for research on lisinopril's effects on lipid peroxidation in hypertensive rats. Her scholarly impact is evident with 675 citations and an h-index of 16 according to UNIS metrics. Dr. KIRBAŞ actively contributes to her field through editorial work for journals including Current Research in Health Sciences and The Eurasian Journal of Medicine, and maintains professional memberships in the Turkish Clinical Biochemistry Association, Turkish Biochemistry Association, and Clinical Biochemistry Specialists Association. Her teaching portfolio includes numerous biochemistry courses covering topics from vitamin metabolism to laboratory quality control.

Zackary Fallsمشاهده پروفایل

استادیار

• Biomedical Informatics
• Computational Drug Discovery
• Pharmacoinformatics
• +۹ مورد دیگر

Dr. Zackary Falls is an Assistant Professor in the Department of Biomedical Informatics at the Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, where he leads a data-centric computational laboratory focused on drug discovery and pharmacoinformatics. Education & Training PhD, Computational Chemistry, University at Buffalo, 2017 BS, Chemistry, Canisius College, 2012 NLM T15 Postdoctoral Fellowship, Jacobs School of Medicine and Biomedical Sciences, 2020 Research Interests His group integrates structural bioinformatics, chemoinformatics, and clinical informatics to develop and apply the multiscale CANDO drug-discovery platform. Current thrusts include: AI-driven design of non-addictive analgesics and overdose-rescue drugs targeting the opioid crisis. Repurposing FDA-approved drugs against COVID-19. Rational design of combination therapies for KRAS-driven non-small-cell lung cancer. Large-scale analytics on EHR and Medicaid claims to understand health disparities in addiction treatment. Scientific Awards Sinsheimer Scholar Award 2024 T15 Informatics Training Fellowship Award 2017 Marjorie Winkler Fellowship Award 2012, Gordon Harris Fellowship Award 2012, Merck Index Award 2012 Funding & Grants Since 2020, Dr. Falls has served as PI or Co-I on grants totaling ≈ $35 million from NIH (NIDA, NCATS, NLM), NIST, Empire AI, and private foundations. Key projects include: Principal Investigator, “A translational bioinformatics approach to elucidate and mitigate polypharmacy-induced adverse drug reactions,” NIDA, $1.05 M, 2022-2027. Co-Principal Investigator, CTSA SUNY Buffalo Hub, NCATS, $29.2 M, 2025-2031. Co-Investigator, “BRIGHT Short-Term Training,” NLM, $0.67 M, 2022-2027. Group & Collaborations He leads the Falls Group , currently mentoring three trainees and collaborating closely with Prof. Ram Samudrala’s team and multiple academic/industry partners. The lab is housed within UB’s Center for Computational Research and the Witebsky Center for Microbial Pathogenesis and Immunology.

• Spine Surgery
• Orthopaedic Surgery
• Minimally Invasive Surgery
• +۹ مورد دیگر

Arya Varthi, MD, is an Associate Professor in the Department of Orthopaedics & Rehabilitation at Yale School of Medicine, where he also serves as the Spine Surgery Fellowship Director. He is a board-certified orthopaedic surgeon specializing in minimally invasive and open spine surgeries of the cervical, thoracic, and lumbar spine, treating conditions including trauma, deformity, tumors, and degenerative disorders. Associate Professor of Orthopaedics & Rehabilitation, Yale School of Medicine Spine Surgery Fellowship Director Board Certified, American Board of Orthopaedic Surgery Member, North American Spine Society Education and Training: BA, Economics, University of Chicago (Phi Beta Kappa) MD, University of Connecticut School of Medicine Residency, Orthopaedic Surgery, Yale New Haven Hospital Fellowship, Spine Surgery, Rush University Medical Center Dr. Varthi's research is centered on spine surgery outcomes, with a focus on minimizing complications and improving patient recovery. His work spans epidemiological studies on spinal injuries, risk factor analysis for surgical complications, and evaluations of emerging treatments such as semaglutide in diabetic patients undergoing spine fusion. He investigates the impact of comorbidities like sickle cell disease, lupus, and obstructive sleep apnea on surgical outcomes, contributing to more personalized and safer care. His 15 most recent publications reflect a strong trend in clinical outcomes research, particularly in anterior cervical discectomy and fusion (ACDF), posterior lumbar fusion, and the management of complex spine pathologies. The articles emphasize patient safety, complication prevention, and the use of national databases and multicenter collaborations to drive evidence-based practice. Key themes include risk stratification, perioperative optimization, and the evaluation of new technologies and pharmacological interventions in spine care. Scientific Awards and Honors: Todd Albert Scholar Award, AANS Spine Summit (2025) Ogilvie Spine Research Award, Yale School of Medicine (2018) Golden Apple Fellow Award, Rush University Medical Center (2017) Yale Power Day Resident Award (2016) AOA Resident Leadership Forum, American Orthopaedic Association (2015) Dr. Varthi is actively involved in clinical education and mentorship as the fellowship director, shaping the next generation of spine surgeons. He collaborates extensively with colleagues such as Dr. Jonathan N. Grauer and Dr. Daniel R. Rubio, contributing to both research and national presentations. He has no reported grants listed in the text, but his research is supported through institutional affiliations and professional society recognition. Labs and Teams: Dr. Varthi is affiliated with the Yale Spine Center and the Spondyloarthritis Program, working within multidisciplinary teams that integrate orthopaedics, neurology, and physical medicine to provide comprehensive spine care. His research is conducted in collaboration with frequent co-authors at Yale, forming a robust clinical research group focused on advancing spinal surgery practices.

• Osteoporosis
• Bone Health
• Fracture Risk Assessment
• +۳ مورد دیگر

John Anthony Kanis is a Researcher (past) affiliated with the Mary MacKillop Institute for Health Research within the Faculty of Health Sciences . His work focuses on osteoporosis, bone health, and fracture risk assessment, particularly through the development and application of the FRAX tool. He has contributed extensively to understanding sarcopenia, geriatric medicine, and the intersection of chronic diseases like dementia and cancer with bone health. His research emphasizes translational studies, including clinical trials evaluating vitamin D, omega-3 supplements, and exercise programs. He collaborates globally to refine intervention thresholds and promote equitable osteoporosis management in diverse populations, including conflict zones. Key contributions include calibrating FRAX models for race-specific populations and assessing cost-effectiveness of therapies like romosozumab. Recent studies highlight the role of sarcopenia in fracture risk, the predictive value of clinical and biochemical markers, and strategies to mitigate falls in aging populations. His work bridges epidemiology, clinical practice, and public health policy to improve bone health outcomes worldwide.

• Falls Prevention
• Physical Activity and Aging
• Gerontology
• +۴ مورد دیگر

Professor Anne Tiedemann is a leading academic in physical activity and health at the Sydney School of Public Health , University of Sydney. She heads the Healthy Ageing research theme at the Institute for Musculoskeletal Health, a collaboration with Sydney Local Health District. Her work focuses on scalable strategies to promote physical activity and prevent falls in older adults, with significant contributions to WHO guidelines. She holds executive roles in the World Falls Society and Australian and New Zealand Falls Prevention Society, and co-leads the Older Adults Work Plan for the WHO Collaborating Centre for Physical Activity, Nutrition and Obesity. Her research interests include falls risk assessment, exercise adherence predictors, yoga's role in mobility, policy translation, and allied health professional education. Current projects involve the Active Women over 50 initiative, Choose To Move Sydney, and international collaborations like the SAGE yoga trial in Brazil and the peer-volunteer exercise support project in the UK. Professor Tiedemann has secured over $27 million in grant funding and authored 180+ publications (H-index 53). Her recent work emphasizes telehealth adaptations, program design for marginalized populations, and cost-effectiveness of interventions. Awards include the NHMRC Research Excellence Award (2016), Sydney Research Young Researcher Award (2017), and Robinson Fellowship (2019). Advising and grants: She supervises students Ima Strkljevic and Geraldine Wallbank, focusing on volunteer professional skill utilization and physical activity strategies. Grants support trials evaluating exercise programs, yoga, and digital health solutions. International collaborations span Brazil (University of Sao Paulo) and the UK (University of Birmingham). Labs/Teams: Core member of the Sydney Centre for Healthy Societies. Leads interdisciplinary teams in fall prevention and healthy aging initiatives, integrating clinical research with policy development.

Christophe Grafمشاهده پروفایل

استادیار

• Geriatrics
• Aging Populations
• COVID-19 in Elderly
• +۴ مورد دیگر

Christophe Graf is an Assistant Professor and Chief Physician at Geneva University Hospitals (HUG), affiliated with the University of Geneva. His clinical and research focus centers on geriatrics, with expertise in aging-related conditions, COVID-19 impacts on elderly populations, frailty assessment, and innovative rehabilitation approaches. His research explores: Geriatric care models for neurodegenerative diseases and multimorbidity Nutritional interventions and body composition analysis in aging Digital health technologies (AI wearables, serious games) for rehabilitation Pandemic responses in long-term care settings, including infection control and post-COVID sequelae Recent publications (2022-2024) demonstrate strong thematic coherence around geriatric adaptations to global health challenges, with 73% focusing on COVID-19 impacts and 27% on technological innovations in elderly care. The work shows increasing interdisciplinary collaboration across neurology, virology, and digital health fields. While no awards or student mentees are documented in the provided text, Graf contributes significantly to multicenter studies on aging and maintains active research partnerships across European institutions.

• Geriatrics
• Fall Prevention
• Frailty Assessment
• +۳ مورد دیگر

Natalie A. Sanders is an Associate Professor of Clinical Internal Medicine in the Division of Geriatrics at the University of Utah, specializing in faint, fall, and frailty syndromes with expertise in delirium prevention. She serves as Program Director for the ACGME-approved Geriatric Fellowship and will assume Medical Directorship of the University of Utah Madsen Geriatrics Clinic in July 2023, while maintaining clinical practice at the University of Utah Geriatrics Clinic and leadership in the Hospital Elder Life Program (HELP). Her educational journey includes: B.S. in Biological Sciences from the University of Nevada D.O. from Western University of Health Sciences Internal Medicine Internship, Residency, and Geriatrics Fellowship at University of Utah School of Medicine (serving as Chief Medical Resident) Dr. Sanders' research centers on geriatric syndromes, investigating baroreceptor function in fall pathogenesis, testosterone-exercise interventions for fracture prevention, and prognostic value of frailty assessments. She actively disseminates the Patients Priority Care framework to align clinical practice with patient-centered goals, supporting the University of Utah's Age Friendly Health System accreditation through evidence-based approaches to elder care. Her publication record (2011-2019) demonstrates consistent focus on fall prevention, frailty assessment, and cardiovascular-geriatric interfaces, with significant contributions to clinic model innovation, cost analysis of specialized geriatric services, and educational frameworks for interdisciplinary care. These works collectively advance the understanding of multifactorial geriatric syndromes through rigorous clinical investigation and practical implementation science. Her professional recognition includes: Fellow of the American College of Physicians (FACP) Dr. Sanders mentors medical students, residents, and geriatric fellows while co-leading the Medicine-Geriatrics integrated residency/fellowship program. Her leadership extends to the pioneering University of Utah Faint and Fall Clinic (where she expanded frailty assessments as Medical Director) and the HELP program, both critical to the institution's national recognition in age-friendly care. Current initiatives focus on scaling Patients Priority Care implementation and refining fall prevention protocols through multidisciplinary collaboration across clinical and academic units. She directs clinical operations for geriatric services at the Madsen Health Center while contributing to national geriatric education through American Geriatrics Society curricula, maintaining active roles in both clinical innovation and training the next generation of geriatric specialists.

• Aging
• Geriatrics
• Clinical Epidemiology
• +۴ مورد دیگر

Thomas M. Gill is the Humana Foundation Professor of Geriatric Medicine at Yale University and holds concurrent appointments as Professor of Epidemiology (Chronic Diseases) and Investigative Medicine. He directs the Yale Claude D. Pepper Older Americans Independence Center , the Yale Program on Aging , and the Yale Center for Disability and Disabling Disorders . His research focuses on the epidemiology and prevention of disability in older adults, particularly through longitudinal studies like the Yale Precipitating Events Project (PEP) and the National Health and Aging Trends Study (NHATS) . Education: MD, University of Chicago (1987) Residency, University of Washington (1990) Fellowship, Yale University (1993-1994) Research Interests: Dr. Gill's work spans aging, disability evaluation, clinical epidemiology, and health disparities. He has led multi-site clinical trials comparing dementia care models and developed interventions for prehabilitation to prevent functional decline in frail older adults. His team also investigates the impact of environmental factors (e.g., extreme heat) on hospitalization risks in older populations. Scientific Awards & Leadership: Recipient of the Irving Wright Award of Distinction (2022) and the Joseph T. Freeman Award (2012), Dr. Gill is a member of the American Society for Clinical Investigation and the Association of American Physicians. He leads NIH-funded initiatives, including a translational geroscience working group with annual pilot grants.